EUCTR2016-002162-30-BE进行中（未招募）1 期
Prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution in patients undergoing elective abdominal surgery - PHOENICS
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 2,280
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male or female adult patients > 40 and <= 85 years of age
- •Women of childbearing potential must test negative on standard pregnancy test (urine or serum)
- •Patients undergoing elective abdominal surgery with an expected blood loss of at least 500 ml
- •ASA Physical Status II-III
- •Signed written consent form
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1500
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 780
排除标准
- •Hypersensitivity to the active substances or to any of the other excipients of the investigational products
- •Body weight = 140 kg
- •Renal impairment (AKIN stage = 1 or chronic) or acute and/or chronic renal replacement therapy
- •Intracranial or cerebral haemorrhage
- •Critically ill patients (typically admitted to the intensive care unit)
- •Dehydration
- •Hyperhydration
- •Pulmonary oedema
- •Congestive heart failure
- •Severe hypernatremia
- •Severe Hyperchloraemia
- •Hyperkalemia
- •Metabolic alkalosis
- •Severely impaired liver function
- •Severe coagulopathy
- •Organ transplant patients
- •Simultaneous participation in another interventional trial (drugs or medical device)
研究者
相似试验
尚未招募
不适用
Prospective, randomized, controlled, double-blind clinical study of traditional Chinese medicine combined with glucocorticoid in the treatment of generalized myasthenia gravisMyasthenia GravisITMCTR2100005054Zhejiang Provincial Hospital of Traditional Chinese Medicine
进行中（未招募）
1 期
Efficacy of nebulized 4.2% sodium-bicarbonate in COVID-19 pneumoniasevere COVID-19 pneumonia requires invasive ventillatory supportMedDRA version: 23.1Level: LLTClassification code 10084564Term: SARS-CoV-2 pneumoniaSystem Organ Class: 100000004862EUCTR2021-001665-20-HUSemmelweis University Department of Oralbiology200
已完成
不适用
Prospective, randomized, double-blind, controlled trial of the healing effect of Polaprezinc for NSAIDs induced small bowel injury.SAIDs-induced small bowel injuryJPRN-UMIN000001538Division of Gastroenterology,Department of Internal Medicine, Keio University40
已完成
不适用
Prospective, randomized, double-blind, controlled study for the incidence of small bowel mucosal injury caused by selective COX-2 inhibitor in healthy volunteersSmall bowel mucosal injuryJPRN-UMIN000003871Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University40
进行中（未招募）
1 期
Efficacy and Safety Evaluation for the Treatment of house dust mite induced allergic asthma and rhinitis/rhinoconjunctivitisEtiological treatment of mild to moderate controlled intermittent or persistent allergic asthma and intermittent or persistent allergic rhinitis / rhinoconjunctivitisMedDRA version: 20.0Level: LLTClassification code 10020419Term: House dust mite allergySystem Organ Class: 100000004870MedDRA version: 21.1Level: LLTClassification code 10034382Term: Perennial allergic rhinitisSystem Organ Class: 100000004855MedDRA version: 20.0Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853MedDRA version: 21.1Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 100000004855EUCTR2021-003014-39-ESInmunotek, S.L.400